Cadila Healthcare's Company Signs 3 Share Purchase Agreements To Acquire Amplitude Surgical, Eyes Over 90 per cent Ownership Through Block Deal And Tender Offer
Cadila Healthcare's Company Signs 3 Share Purchase Agreements To Acquire Amplitude Surgical, Eyes Over 90 per cent Ownership Through Block Deal And Tender Offer
In a year, the stock has declined by 8 per cent while in last 3 years the stock has jumped by 151 per cent.
In a year, the stock has declined by 8 per cent while in last 3 years the stock has jumped by 151 per cent.
Watch Out For These Penny Stocks Locked In The Upper Circuit on April 09, 2025
Among all BSE-listed companies, 183 stocks were locked in the upper circuit, and 200 stocks were locked in the lower circuit.
This Lifesciences Company Secures USFDA Approval for Eluxadoline Tablets with 180-Day Exclusivity; Stock Price Logged 135.25 per cent Returns in 3 years
This Lifesciences Company Secures USFDA Approval for Eluxadoline Tablets with 180-Day Exclusivity; Stock Price Logged 135.25 per cent Returns in 3 years
With a PE ratio of 20x, the company trades at a discount compared to the industry PE of 28x. The company has ROCE of 22.3 per cent and ROE of 20.7 per cent.
Zydus group Company Invests in Illexcor for Sickle Cell Treatment; Stock Gave 139.65 per cent in last 3 Years
Zydus group Company Invests in Illexcor for Sickle Cell Treatment; Stock Gave 139.65 per cent in last 3 Years
Over the past three years, the stock has delivered a substantial return of 139.65 per cent, classifying it as a multibagger stock.
New Drug Launch: Transforming Cardiometabolic Care in India
New Drug Launch: Transforming Cardiometabolic Care in India
Glenmark Pharmaceuticals Ltd, a prominent global pharmaceutical company, has expanded its cardiometabolic portfolio by launching Empagliflozin and its fixed-drug combinations in India.
The company continues to strengthen its presence in the cardiometabolic care segment, addressing the rising prevalence of diabetes and cardiovascular diseases in India.
Pharma Stock Soars 4 per cent Following FDA Approval and Strategic Partnership with Leading US Company
FDA Nod for Key Diabetes Treatment Boosts Market Confidence and Stock Performance
FDA Nod for Key Diabetes Treatment Boosts Market Confidence and Stock Performance
This pharma company's shares surged to a new 52-week high after receiving final approval from the USFDA.
The share has delivered over 95 per cent returns in the past year, transforming into a multi-bagger with over 260 per cent returns in the last two years.
The share has delivered over 95 per cent returns in the past year, transforming into a multi-bagger with over 260 per cent returns in the last two years.
Don’t miss the action in this pharmaceutical stock: The Cup and handle pattern breakout is seen with huge volumes!
Notably, the RSI has entered a super bullish territory, indicating a significant shift in momentum.
The Nifty Pharmaceutical index has surged by an impressive 30 per cent on a year-to-date basis in 2023, significantly outperforming the Nifty 50 index. Against the backdrop of India experiencing a single-day spike of 628 new COVID-19 cases
Stocks to watch: These small-cap stocks will be in focus on Friday!
Among the BSE Smallcap gainers were Astec Lifesciences, Syncom Formulations, Suzlon Energy and NBCC
On Wednesday, the Sensex gained by 346 points to close at 57,960.09, while the Nifty 50 surged by 129 points to close at 17,080.70
Overnight Digest: Stocks to keep an eye on February 07!
Watch out for these large-cap stocks in Tuesday’s trading session!
Watch out for these large-cap stocks in Tuesday’s trading session!
Overnight Digest: Stocks to be watched on August 12
Keep an eye on these stocks for Friday's trading session.
Benchmark indices registered a positive close on Thursday with Sensex gaining 500 points while Nifty advancing 124 points.
Stocks to watch: These small-cap stocks will be in focus tomorrow!
PC Jeweller, Ethos Ltd, Mirza International, Himadri Speciality Chemical, Shalimar Paints, Elecon Engineering, Sterling Tools, Brand Concepts, Kernex Microsystems, Sumitomo Chemical India, and Phoenix Mills made a fresh 52-week high today
BSE Smallcap index bucked the negative trend to outperform broader markets, climbing 1.07 per cent and ending the session at 25,916.41.